You are here: 

Stories

Dr Robert Day Targeting an “evil twin” enzyme in prostate cancer

Investing to reduce cancer burden

Icon - piggy bank

Last year CCS funded $40 million in cancer research, thanks to our donors. Discover how you can help reduce the burden of cancer.

Learn more